13F

Stock

Acadia Pharmaceuticals Inc

ACAD · held by 5 managers

Reported value

$29.8M

Holders

5

+1 new · −0 exited

Holders’ est. mark

−$435.5K

Price effect on 2 books still in the name

Largest holder

$23.6M

NORGES BANK

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
NORGES BANK1.42M$23.6MHeld
BARCLAYS PLC248.4K$4.13M−$432.3KCut−$1.35M
DANSKE BANK A/S79.9K$1.33MNew
VIRTUS ADVISERS, LLC43K$713.8KHeld
Leonteq Securities AG2.3K$38.2K−$3.25KAdded$4.12K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.